Hollywood Producer Anthony J. Cataldo has made over a dozen feature films including “Replicant” (2001), “Shortcut to Happiness” (2003) and “Escape to Grizzly Mountain” (2004), and has worked with actors/directors such as Gus Van Sant, Anthony Hopkins, Christopher Walken, Alec Baldwin, Martin Landau, Jean Claude Van Damm, to name a few. Anthony Cataldo was Chairman and CEO of Miracle Entertainment (formerly Cannon Films) for four years. He is currently working on his next film “701 The Movie.” Other positions include: Chairman and Chief Executive Officer and Director. Mr. Cataldo served as Chief Executive Officer and Chairman of VoIP, Inc. from September 2006 through April 2008. During the past five years, Mr. Cataldo has served as non-executive chairman of the board of directors of BrandPartners Group, Inc., a provider of integrated products and services dedicated to providing financial services and traditional retail clients with turn-key environmental solutions from October 2003 through August 2006. Mr. Cataldo also served as non-executive co-chairman of the board of MultiCell Technologies, Inc., a supplier of functional, non-tumorigenic immortalized human hepatocytes from February 2005 through July 2006. Mr. Cataldo has also served as executive chairman of Calypte Biomedical Corporation, a publicly traded biotechnology company, involved in the development and sale of urine based HIV-1 screening tests from May 2002 through November 2004. Prior to that, Mr. Cataldo served as the Chief Executive Officer and Chairman of the Board of Directors of Miracle Entertainment, Inc., a Canadian film production company, from May 1999 through May 2002, where he was the executive producer or producer of several motion pictures. From August 1995 to December 1998, Mr. Cataldo served as President and Chairman of the Board of Senetek, PLC, a publicly traded biotechnology company involved in age-related therapies. Most recently, From February 2011 to June 2013, Mr. Cataldo served as Chairman and CEO/ Founder of Genesis Biopharma, Inc. Mr. Cataldo created Genesis Biopharma with the inclusion of assets purchased from the National Cancer Institute (NIH) for their novel treatment of Stage Four Cancer treatment for melanoma.
Roger Marsh - MUFON News Editor
Roger is a UFO writer, author, playwright and independent filmmaker. Roger is also the editor for the MUFON Journal.
MUFON News Archives
MUFON News Categories